NeuroBo Pharmaceuticals Inc (NRBO):企業の財務・戦略的SWOT分析

◆英語タイトル:NeuroBo Pharmaceuticals Inc (NRBO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1661
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NeuroBo Pharmaceuticals Inc (NRBO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroBo Pharmaceuticals Inc (NeuroBo), formerly Gemphire Therapeutics Inc, is a clinical stage biopharmaceutical company that focuses on developing novel therapeutics for neurodegenerative and cardiometabolic diseases. The company pipeline product candidates include Gemcabene for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular diseases; NB-01 for painful diabetic neuropathy (PDN); and NB-02 for neurodegenerative diseases such as Alzheimer’s disease and tauopathies. The company has research facilities in South Korea. NeuroBo is headquartered in Boston, Massachusetts, the US.

NeuroBo Pharmaceuticals Inc Key Recent Developments

Jan 13,2020 NeuroBo Pharmaceuticals complete Gemphire merger
Aug 09,2019 Gemphire Therapeutics reports second quarter 2019 financial results and provides corporate update
Jul 25,2019 Gemphire to merge with NeuroBo Pharmaceuticals
Mar 15,2019 Gemphire Therapeutics reports fourth quarter and fiscal year 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
NeuroBo Pharmaceuticals Inc – Key Facts
NeuroBo Pharmaceuticals Inc – Key Employees
NeuroBo Pharmaceuticals Inc – Key Employee Biographies
NeuroBo Pharmaceuticals Inc – Major Products and Services
NeuroBo Pharmaceuticals Inc – History
NeuroBo Pharmaceuticals Inc – Company Statement
NeuroBo Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
NeuroBo Pharmaceuticals Inc – Business Description
NeuroBo Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
NeuroBo Pharmaceuticals Inc – Strengths
NeuroBo Pharmaceuticals Inc – Weaknesses
NeuroBo Pharmaceuticals Inc – Opportunities
NeuroBo Pharmaceuticals Inc – Threats
NeuroBo Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
NeuroBo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroBo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
NeuroBo Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 13, 2020: NeuroBo Pharmaceuticals complete Gemphire merger
Aug 09, 2019: Gemphire Therapeutics reports second quarter 2019 financial results and provides corporate update
Jul 25, 2019: Gemphire to merge with NeuroBo Pharmaceuticals
Mar 15, 2019: Gemphire Therapeutics reports fourth quarter and fiscal year 2018 financial results
Jan 09, 2019: NeuroBo to start trial of NB-01 for diabetic neuropathic pain
Jan 07, 2019: NeuroBo selects AiCure to advance pivotal neuropathic pain clinical trial
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
NeuroBo Pharmaceuticals Inc, Key Facts
NeuroBo Pharmaceuticals Inc, Key Employees
NeuroBo Pharmaceuticals Inc, Key Employee Biographies
NeuroBo Pharmaceuticals Inc, Major Products and Services
NeuroBo Pharmaceuticals Inc, History
NeuroBo Pharmaceuticals Inc, Subsidiaries
NeuroBo Pharmaceuticals Inc, Key Competitors
NeuroBo Pharmaceuticals Inc, Ratios based on current share price
NeuroBo Pharmaceuticals Inc, Annual Ratios
NeuroBo Pharmaceuticals Inc, Annual Ratios (Cont...1)
NeuroBo Pharmaceuticals Inc, Interim Ratios
NeuroBo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroBo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
NeuroBo Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
NeuroBo Pharmaceuticals Inc, Performance Chart (2015 - 2019)
NeuroBo Pharmaceuticals Inc, Ratio Charts
NeuroBo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroBo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[NeuroBo Pharmaceuticals Inc (NRBO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nine Dragons Paper (Holdings) Ltd
    Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Paramo AS:企業の戦略的SWOT分析
    Paramo AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Black Box Corp (BBOX):企業の財務・戦略的SWOT分析
    Black Box Corp (BBOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kineta Inc-製薬・医療分野:企業M&A・提携分析
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • BioStar Pharmaceuticals Inc (BSPM):企業の財務・戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Symbolic Displays, Inc.:企業の戦略・SWOT・財務情報
    Symbolic Displays, Inc. - Strategy, SWOT and Corporate Finance Report Summary Symbolic Displays, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Statkraft AS:企業のM&A・事業提携・投資動向
    Statkraft AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statkraft AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • SK Innovation Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PDC Energy Inc (PDCE):石油・ガス:M&Aディール及び事業提携情報
    Summary PDC Energy Inc (PDC Energy) is an oil and gas company that offers production, development, exploration and marketing of crude oil, natural gas and natural gas liquids. The company provides horizontal drilling and low-risk organic development of oil and natural gas reserves from shales and ti …
  • DocCheck AG (AJ91):企業の財務・戦略的SWOT分析
    DocCheck AG (AJ91) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pengrowth Energy Corp (PGF):石油・ガス:M&Aディール及び事業提携情報
    Summary Pengrowth Energy Corp (Pengrowth) is an oil and gas company that explores, acquires, develops and produces oil and natural gas reserves. The company's services include development of large accumulations of oil, bitumen and natural gas. Its projects include Lindbergh thermal project, conventi …
  • Latin American Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Latin American Resources Ltd (LAR) is an oil and gas company that offers exploration and development of natural resource properties for the production of oil and natural gas. The company's services include acquiring and developing oil and gas properties and its operational assets to achieve …
  • Movenpick Schweiz AG:企業の戦略・SWOT・財務情報
    Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report Summary Movenpick Schweiz AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sumitomo Bakelite Co Ltd (4203):企業の財務・戦略的SWOT分析
    Sumitomo Bakelite Co Ltd (4203) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Innocoll AG (INNL)-医療機器分野:企業M&A・提携分析
    Summary Innocoll AG (Innocoll), formerly Innocoll Holdings Inc is a specialty pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product portfolio includ …
  • Probiogen AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Probiogen AG (Probiogen) a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeut …
  • Silver Fern Farms Limited:企業の戦略的SWOT分析
    Silver Fern Farms Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Clark Enterprises Inc:企業の戦略・SWOT・財務情報
    Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hibbett Sports Inc:戦略・SWOT・企業財務分析
    Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report Summary Hibbett Sports Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NSK Ltd.:企業の戦略・SWOT・財務分析
    NSK Ltd. - Strategy, SWOT and Corporate Finance Report Summary NSK Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆